WO2024253509 - GLYCYRRHIZIC ACID-BASED SEMI-LIQUID CREAM FORMULATION COMBINED WITH SALICYLIC ACID
National phase entry is expected:
Publication Number
WO/2024/253509
Publication Date
12.12.2024
International Application No.
PCT/MX2024/050031
International Filing Date
31.05.2024
Title **
[English]
GLYCYRRHIZIC ACID-BASED SEMI-LIQUID CREAM FORMULATION COMBINED WITH SALICYLIC ACID
[Spanish]
FORMULACIÓN DE CREMA SEMILÍQUIDA A BASE DE ÁCIDO GLICIRRICÍNICO EN COMBINACIÓN CON ÁCIDO SALICÍLICO
[French]
FORMULATION DE CRÈME SEMI-LIQUIDE À BASE D'ACIDE GLYCYRRHIZIQUE EN COMBINAISON AVEC DE L’ACIDE SALICYLIQUE
Applicants **
DRAGUSTINOVIS RUIZ, María Esther
2da cda. tezoquipa numero 171, colonia Club de golf México
Ciudad de México, 14620, MX
Inventors
DRAGUSTINOVIS RUIZ, María Esther
2da cda. tezoquipa numero 171, colonia Club de golf México
Ciudad de México, 14620, MX
Priority Data
MX/a/2023/006701
06.06.2023
MX
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
SPTO
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1421 | |
| EPO | Filing, Examination | 4227 | |
| Japan | Filing | 593 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9526 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to a glycyrrhizic acid-based semi-liquid cream formulation combined with salicylic acid, said formulation being effective in treating different pathologies through different variants as a cream, emulsified cream, vaginal-rectal ovule, oral gel cream, vaginal tablets, body shampoo, transdermal patches or intratumoural injections.[Spanish]
Formulación de crema semilíquida a base de ácido glicirricínico en combinación con ácido salicílico, efectiva para atender diferentes patologías, mediante diferentes variantes, en crema, crema emulsionada, ovulo vagino-rectal, crema gel bucal, tabletas vaginales, shampoo corporal, parches transdérmicos o inyecciones intratumorales.[French]
L'invention concerne une formulation de crème semi-liquide à base d'acide glycyrrhizique en combinaison avec de l’acide salicylique, efficace pour traiter différentes pathologies, au moyen de différentes variantes, en crème, crème émulsionnée, ovule vagino-rectal, crème en gel buccal, comprimés vaginaux, shampoing corporel, timbres transdermiques ou injections intratumorales.